Leptin signaling impairs macrophage defenses against


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 08 2019
Historique:
pubmed: 28 7 2019
medline: 26 3 2020
entrez: 28 7 2019
Statut: ppublish

Résumé

The dynamic interplay between metabolism and immune responses in health and disease, by which different immune cells impact on metabolic processes, are being increasingly appreciated. However, the potential of master regulators of metabolism to control innate immunity are less understood. Here, we studied the cross-talk between leptin signaling and macrophage function in the context of bacterial infections. We found that upon infection with Gram-negative pathogens, such as

Identifiants

pubmed: 31350351
pii: 1904885116
doi: 10.1073/pnas.1904885116
pmc: PMC6697794
doi:

Substances chimiques

Leptin 0
Receptors, Leptin 0
Mechanistic Target of Rapamycin Complex 2 EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
PHLPP1 protein, mouse EC 3.1.3.16
Phosphoprotein Phosphatases EC 3.1.3.16

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16551-16560

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK026687
Pays : United States

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Immunity. 2016 Mar 15;44(3):439-449
pubmed: 26982352
Immunity. 2010 Dec 14;33(6):929-41
pubmed: 21145759
J Cell Physiol. 2009 Oct;221(1):189-94
pubmed: 19492417
Cell. 1996 May 31;85(5):639-50
pubmed: 8646773
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
mBio. 2014 Dec 16;5(6):
pubmed: 25516614
J Immunol. 2012 Sep 15;189(6):2941-53
pubmed: 22904304
J Biol Chem. 2006 Apr 21;281(16):11374-83
pubmed: 16495224
PLoS Pathog. 2014 Jun 05;10(6):e1004159
pubmed: 24901456
Cell. 2010 Apr 16;141(2):290-303
pubmed: 20381137
J Cell Physiol. 2013 Jun;228(6):1202-9
pubmed: 23129404
BMC Public Health. 2018 Feb 20;18(1):271
pubmed: 29458350
Mol Cell. 2015 Jul 16;59(2):270-84
pubmed: 26118642
Science. 2018 Apr 27;360(6387):449-453
pubmed: 29599194
J Immunol. 2002 Apr 15;168(8):4018-24
pubmed: 11937559
J Cell Biol. 2016 Sep 12;214(6):653-64
pubmed: 27621362
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14564-9
pubmed: 19667176
J Cell Biol. 2017 Feb;216(2):343-353
pubmed: 28143890
Am J Physiol. 1998 Jul;275(1):R29-32
pubmed: 9688956
Biomed Res Int. 2013;2013:487081
pubmed: 23484124
J Immunol. 2011 Oct 1;187(7):3776-84
pubmed: 21859958
Endocrinology. 2009 Jul;150(7):3083-91
pubmed: 19342450
PLoS Genet. 2010 May 06;6(5):e1000938
pubmed: 20463885
Trends Mol Med. 2016 Feb;22(2):88-98
pubmed: 26776093
J Immunol. 2018 Jul 15;201(2):371-382
pubmed: 29866702
Mol Biol Cell. 2016 Jan 15;27(2):321-33
pubmed: 26582390
Oncogene. 2014 Jan 2;33(1):74-84
pubmed: 23178499
Microbes Infect. 2011 Dec;13(14-15):1177-84
pubmed: 21835260
J Immunol Methods. 2014 Jun;408:89-100
pubmed: 24857755
Nature. 2018 Apr 5;556(7699):113-117
pubmed: 29590092
J Clin Invest. 2011 Mar;121(3):1191-8
pubmed: 21393862
Front Cell Infect Microbiol. 2017 Sep 29;7:428
pubmed: 29034217
Nat Commun. 2017 Feb 06;8:14338
pubmed: 28165011
Science. 2008 Jun 13;320(5882):1496-501
pubmed: 18497260
Infect Immun. 2009 Mar;77(3):1008-14
pubmed: 19103772
J Vis Exp. 2017 Oct 25;(128):
pubmed: 29155747
J Biol Chem. 2008 Jan 25;283(4):2203-10
pubmed: 18039669
Nat Immunol. 2012 Oct;13(10):954-62
pubmed: 22922364
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
PLoS One. 2014 Sep 18;9(9):e108138
pubmed: 25232724
Traffic. 2008 Nov;9(11):1936-47
pubmed: 18764820
PLoS Pathog. 2017 Feb 13;13(2):e1006227
pubmed: 28192515
Mol Biol Cell. 2001 Jan;12(1):155-70
pubmed: 11160830
Epidemiology. 2015 Jul;26(4):580-9
pubmed: 25978794
Cell Host Microbe. 2012 Jun 14;11(6):563-75
pubmed: 22704617
Cytokine Growth Factor Rev. 2017 Jun;35:71-84
pubmed: 28285098
Trends Mol Med. 2013 Aug;19(8):487-500
pubmed: 23746697
Am J Physiol Lung Cell Mol Physiol. 2018 Jul 1;315(1):L78-L86
pubmed: 29565180
Nat Rev Microbiol. 2004 Sep;2(9):747-65
pubmed: 15372085
Science. 2005 Feb 18;307(5712):1098-101
pubmed: 15718470

Auteurs

Julia Fischer (J)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Department I of Internal Medicine, University of Cologne, D-50937 Cologne, Germany.
Division of Infectious Diseases, University of Cologne, D-50937 Cologne, Germany.
Partner Site Bonn-Cologne, German Center for Infection Research (DZIF), D-50931 Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany.

Saray Gutièrrez (S)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany.

Raja Ganesan (R)

Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide SA 5001, Australia.

Chiara Calabrese (C)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.

Rajeev Ranjan (R)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.

Gökhan Cildir (G)

Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide SA 5001, Australia.

Nina Judith Hos (NJ)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Partner Site Bonn-Cologne, German Center for Infection Research (DZIF), D-50931 Cologne, Germany.
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany.

Jan Rybniker (J)

Department I of Internal Medicine, University of Cologne, D-50937 Cologne, Germany.
Division of Infectious Diseases, University of Cologne, D-50937 Cologne, Germany.
Partner Site Bonn-Cologne, German Center for Infection Research (DZIF), D-50931 Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany.
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany.

Martina Wolke (M)

Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany.

Jochen W U Fries (JWU)

Institute of Pathology, University of Cologne, D-50931 Cologne, Germany.

Vinay Tergaonkar (V)

Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide SA 5001, Australia.
Laboratory of NF-κB Signaling, Institute of Molecular and Cell Biology, Proteos, 138673 Singapore, Singapore.
Department of Biochemistry, National University of Singapore (NUS), 117597 Singapore.
Department of Pathology, Yong Loo Lin School of Medicine, NUS, 117597 Singapore.

Georg Plum (G)

Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany.

Adam Antebi (A)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Molecular Genetics of Ageing Laboratory, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Nirmal Robinson (N)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany; nirmal.robinson@unisa.edu.au.
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany.
Center for Cancer Biology, University of South Australia and SA Pathology, Adelaide SA 5001, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH